FWIW....the response submitted Jan. 5 to the '890 OA has yet to

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

eggbert

Rank: Vice President [?]

Points: 2740 [?]

Votes: 55 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

FWIW....the response submitted Jan. 5 to the '890 OA has yet to

posted on Feb 10, 2010 01:59PM

be posted at the USPTO except to show that a response has been received. It is not yet available for public viewing. I wonder why that is?

4. U.S. Patent No. 5,530,890 Patent (the “’890 Patent”) The PTO issued a non-final Office action on November 5, 2009, rejecting asserted claims 1, 2 and 7 but affirming asserted claim 9 dependent from rejected claim 1. TPL filed its response on January 5, 2010. The PTO is currently considering TPL’s response, and is expected to issue an Office action.